Regencell Bioscience Holdings Ltd (RGC) — Capital Expenditures

Annual figures by fiscal year, from SEC filings.

2020: $117.8K2022: $780.9K2023: $27.4K2024: $5.4K2025: $152.7K$152.7K
2020Capital Expenditures (USD)2025
Fiscal YearCapital ExpendituresChange YoY
2025$152.7K+2740.2%
2024$5.4K-80.4%
2023$27.4K-96.5%
2022$780.9K
2020$117.8K